QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

TRAX

QT72First Tracks Biotherapeutics Inc
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
17.42
-0.75-4.13%
OverviewShort InterestFilings
TRAXQT72First Tracks Biotherapeutics Inc·NASDAQ
OverviewShort InterestFilings
17.42-4.13%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own-
Shs Outstand34.89M
Perf Week2.29%
Market Cap633.99MForward P/E-EPS next Y-Insider Trans0.00%Shs Float-Perf Month4.56%
Enterprise Value385.53MPEG-EPS next Q-Inst Own-Short Float-Perf Quarter-
Income-98078959.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y-
Sales-P/B2.45EPS next Y-ROA-33.62%Short Interest-Perf YTD-
Book/sh8.23P/C-EPS next 5Y-ROE-30.10%52W High-Perf Year-
Cash/sh8.94P/FCF-EPS past 3/5Y-ROIC-40.43%52W Low-Perf 3Y-
Dividend Est.-EV/EBITDA-3.73Sales past 3/5Y-Gross Margin0.00%Volatility6.21% 6.73%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-Oper. Margin0.00%ATR (14)1.87Perf 10Y-
Dividend Ex-Date-Quick Ratio8.74Sales Y/Y TTM-Profit Margin0.00%RSI (14)50.15Recom2.00
Dividend Gr. 3/5Y-Current Ratio8.74EPS Q/Q-SMA203.48%Beta3.03Target Price41.00
Payout0.00%Debt/Eq0.00Sales Q/Q-SMA50-7.64%Rel Volume3.92Prev Close18.17
Employees104LT Debt/Eq0.04Earnings-SMA200-Avg Volume488.25KPrice17.42
IPO DateApr 20, 2026Option/ShortNo / YesEPS/Sales Surpr.-Net Debt/EBITDA2.40Volume1,913,188Change-4.13%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-08-26InitiatedWells FargoOverweight$30
May-04-26InitiatedPiper SandlerOverweight$54
Apr-28-26InitiatedH.CBuy$30
Apr-24-26InitiatedLeerinkOutperform$46
Apr-21-26InitiatedUBSBuy$45
Latest News
Jun-11-26
Jun-11-2605:05PM
12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
Total Revenue
000
Cost of Goods Sold Incl. D&A1401520
Gross Profit-140-1520
Selling, General and Administrative Excl. Other392921
Research and Development14015298
Other Operating Expense-140-152-1
Operating Income-179-181-118
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)
000
Net Income Before Taxes-166-164-106
Income Taxes
000
Consolidated Net Income-166-164-106
Net Income From Continuing Operations-166-164-106
Net Income-166-164-106
EPS (Recurring)0.000.00-3.05
EPS (Basic, Before Extraordinaries)0.000.00-3.05
EPS (Diluted)0.000.00-3.05
EBITDA-178-179-116
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding0035
Market Capitalization
———
Operating Lease Expense
———
Insider Trading Volume
$21.36$19.86$18.36$16.86$15.36● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR